10 Key Points about Biophotonic Therapy
1. Biophotonic Therapy is the use of light to activate the chemiluminescence of the blood, an ancient form of immunity. It is photomedicine and has a well-characterized clinical profile.
2. In BT's extracorporeal form, ultraviolet and visible light are used to treat a small amount of blood, which is then reinfused.
3. In BT's intravenous form, a low-intensity laser (generally at 632.8 nm) shines through a waveguide inside a needle into the blood.
4. Light is a drug. As with all drugs, Biophotonic Therapy's pharmacology includes effects, side effects, indications, and counterindications. BT tends to have fewer side effects than competing synthetic drugs.
5. Invented in the United States, Biophotonic Therapy was first used in 1928 to heal a woman moribund after a septic abortion. The original device has FDA clearance for indications that include various disseminated infections.
6. Biophotonic Therapy is practiced in Russia, Germany, the United States, and other countries. Some 12 books and 400 scientific articles describe Biophotonic Therapy.
7. Biophotonic Therapy is well-characterized at the biochemical level, but its chemiluminescent action requires further study.
8. Biophotonic Therapy forms a central component of the science of biophotonics. Its mechanisms have important implications for pharmacology, physiology, immunology, and neuroscience.
9. Biophotonic Therapy is the leading phototherapeutic treatment of infectious diseases. Its mechanisms of action are the same for all pathogens. There is no evidence that any microbe has ever developed resistance to BT.
10. The failure by established medicine to fund testing of BT as a treatment of HIV/AIDS and other diseases afflicting poor people worldwide is an instance of criminal negligence that must arouse the outrage of all who learn of it.